Implementing the Medicare drug benefit--the first 90 days
Wilensky, G.R.
Healthcare Financial Management Journal of the Healthcare Financial Management Association 60(6): 42-43
2006
ISSN/ISBN: 0735-0732 PMID: 16773984 Document Number: 597301
Document emailed within 1 workday
Related Documents
Gardner, J. 1999: Pharmacists join drug benefit debate. if Medicare offers prescription drug benefit, pharmacists want to be reimbursed Modern Healthcare 29(49): 6Cundiff, D.K. 2003: Medicare prescription drug benefit realities Medgenmed: Medscape General Medicine 5(4): 28
Penna, P. 2004: Outcomes research in the Medicare drug benefit Managed Care Interface 17(1): 19-20
Cook, A.E. 1999: Strategies for containing drug costs: implications for a Medicare benefit Health Care Financing Review 20(3): 29-37
Mueller, C.; Mueller, K.; Sutton, J. 2004: A rural perspective regarding regulations implementing Titles i and Ii of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) Policy Analysis Brief. W Series 24(6): 1-19
Gardner, J. 2001: Double the money. Lawmakers exceed Bush budget request for Medicare reform, drug benefit Modern Healthcare 31(19): 8-9
Daly, R. 2011: Cost-benefit ratio. GOP isn't alone in pushing for Medicare changes Modern Healthcare 41(21): 8-9
Mort, J. 2007: Medication therapy management: a Medicare Part D benefit available to qualifying beneficiaries South Dakota Medicine: the Journal of the South Dakota State Medical Association 60(3): 121
Grimaldi, P. 1993: Latest Medicare benefit: FQHC (Federally Qualified Health Center) services Healthcare Financial Management: Journal of the Healthcare Financial Management Association 47(1): 34; 36 38-40
Oizumi, K.; Rikimaru, T.; Shiraishi, T.; Motohiro, A.; Yoshida, M.; Watanabe, K.; Maruyama, R.; Ishibashi, T.; Kitahara, Y.; Kido, M.; Yoshii, C.; Hara, N.; Ikeda, A.; Yamada, H.; Ninomiya, K.; Matsuzaki, Y.; Ichinose, Y.; Namba, K.; Kodama, T.; Kunitake, R.; Miyazaki, N.; Abe, K.; Matsunaga, R.; Ide, H.; Kamae, I. 1999: Imipenem/cilastatin sodium and other beta-lactams for respiratory tract infections: clinical benefit and treatment days for cure Japanese Journal of Antibiotics 52(1): 1-15
Oizumi, K.; Rikimaru, T.; Shiraishi, T.; Motohiro, A.; Yoshida, M.; Watanabe, K.; Maruyama, R.; Ishibashi, T.; Kitahara, Y.; Kido, M.; Yoshii, C.; Hara, N.; Ikeda, A.; Yamada, H.; Ninomiya, K.; Matsuzaki, Y.; Ichinose, Y.; Namba, K.; Kodama, T.; Kunitake, R.; Miyazaki, N.; Abe, K.; Matsunaga, R.; Ide, H.; Kamae, I. 1999: Imipenem/cilastatin sodium and other beta-lactams for respiratory tract infections: clinical benefit and treatment days for cure Japanese Journal of Antibiotics 52(1): 1-15
Safran, D.Gelb.; Wilson, I.B.; Rogers, W.H.; Montgomery, J.E.; Chang, H. 2002: Primary care quality in the Medicare Program: comparing the performance of Medicare health maintenance organizations and traditional fee-for-service medicare Archives of Internal Medicine 162(7): 757-765
Wagner, L. 1989: Drug benefit underfunded--report Modern Healthcare 19(20): 26
Pry, N.R. 1978: Problems of implementing and coordinating a programmed project grant on drug addiction Journal of Reproductive Medicine 20(6): 337-339
Bower, P. 2009: Drug prevention of hypertension. All cause absolute benefit? Bmj 338: B2597
Scott, L. 1995: AmHS to negotiate drug-benefit alliance Modern Healthcare 25(40): 10
SoRelle, R. 2000: Medicare prescription drug battle heats up Circulation 101(22): E9050-E9051
Charatan, F. 2001: Drug companies defrauded Medicare of millions Bmj 323(7317): 828
Hoffman, R.M. 2000: The clinical benefit of the histoculture drug response assay Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 321-322
Tieman, J. 2003: Senior citizens score win as drug benefit advances Modern Healthcare 33(24): 8-9